Original language | English |
---|---|
Article number | e325 |
Journal | HemaSphere |
Volume | 4 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2020 |
HOVON110/ReBeL Study: Results of the phase i part of a randomized phase I/II study of lenalidomide, rituximab with or without bendamustine in patients with relapsed/refractory follicular lymphoma
Wendy B. C. Stevens*, Katerina Bakunina, Marloes Cuijpers, Martine Chamuleau, Aart Beeker, Rob Fijnheer, Holger Hebart, Hein P. J. Visser, Jeanette K. Doorduijn, Kim Linton, Martin Dreyling, Daphne de Jong, Marie José Kersten
*Corresponding author for this work
Research output: Contribution to journal › Letter › Academic › peer-review